Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S; Nelfinavir Study Group.
Hosogaya N, et al. Among authors: miyazaki t, miyazaki y.
Trials. 2021 Apr 28;22(1):309. doi: 10.1186/s13063-021-05282-w.
Trials. 2021.
PMID: 33910617
Free PMC article.